NAT10 and ovarian carcinoma: In oncological applications, these techniques have been extensively employed to assess ac4C levels and their correlation with NAT10 expression in various cancers, including gastric, lung, and ovarian carcinomas, revealing functional roles for ac4C in promoting tumor cell proliferation, migration, and immune evasion [43–45].